IronBridge Capital Management’s Boston Scientific BSX Stock Holding History

IronBridge Capital Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$14.6M	Sell	588,756 -618,330	-51%	-$15M	0.89%	39
2016 Q4	$26.1M	Sell	1,207,086 -1,710	-0.1%	-$37.3K	1.17%	24
2016 Q3	$28.8M	Sell	1,208,796 -381,130	-24%	-$9.09M	1.32%	21
2016 Q2	$37.2M	Sell	1,589,926 -5,690	-0.4%	-$123K	1.63%	16
2016 Q1	$30M	Buy	1,595,616 +162,495	+11%	+$2.85M	1.21%	27
2015 Q4	$26.4M	Buy	1,433,121 +1,374,050	+2,326%	+$24.6M	1.04%	30
2015 Q3	$969K	Buy	59,071 +6,320	+12%	+$108K	0.04%	163
2015 Q2	$934K	Hold	52,751	–	–	0.03%	163
2015 Q1	$936K	Hold	52,751	–	–	0.03%	167
2014 Q4	$699K	Hold	52,751	–	–	0.02%	179
2014 Q3	$623K	Hold	52,751	–	–	0.02%	189
2014 Q2	$674K	Buy	+52,751	New	+$686K	0.02%	185

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

IronBridge Capital Management's BSX Position: Q1 2017 in Review

IronBridge Capital Management reduced its Boston Scientific (BSX) stake by 51% in Q1 2017, selling an estimated $15M and leaving 588,756 shares worth $14.6M. The position accounts for 0.89% of the portfolio, ranked #39.

IronBridge Capital Management first reported a position in BSX in Q2 2014 and has held it in 12 quarters since. The position peaked at $37.2M in Q2 2016. 552 funds tracked by Wall St. Rank hold BSX as of Q1 2017.

IronBridge Capital Management held 588,756 shares of Boston Scientific worth $14.6M as of Q1 2017.
IronBridge Capital Management sold 618,330 Boston Scientific shares in Q1 2017, an estimated $15M.
Boston Scientific made up 0.89% of IronBridge Capital Management's portfolio in Q1 2017, its #39 holding.
IronBridge Capital Management first reported a position in Boston Scientific in Q2 2014 and has held it in 12 quarters since.
IronBridge Capital Management's Boston Scientific position peaked at $37.2M in Q2 2016.
552 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2017.

Based on IronBridge Capital Management's 13F filing for Q1 2017, filed 10 May 2017.